CJC-1295 is a GHRH analogue studied for changes in GH and IGF-1. Hormone measurements do not by themselves establish muscle gain, fat loss or anti-aging benefits.
What the research shows
A 2006 randomized placebo-controlled study measured pharmacokinetics and GH/IGF-1 responses in healthy adults. A 2009 study examined serum proteins in 11 healthy men. Those measurements are not customer body-composition outcomes. [1] [2]
Distinguishing substances and products
Labels such as with DAC, without DAC, or CJC-1295/ipamorelin require presentation-specific documentation. A shared CJC-1295 name does not automatically establish identity with a research formulation.
Reading a specific brand’s label
Start with the exact substance and product name, then match the label to the manufacturer’s documents. This article does not establish Thai registration or current availability for an unspecified product.
Frequently asked questions
Does higher GH or IGF-1 prove muscle gain?
No. Hormone markers and directly measured muscle outcomes are different endpoints.
Must variants and mixtures be separated?
Yes. Use documentation matching the actual composition.
What information helps identify a specific product?
The brand, product name, full label and matching manufacturer documents. Evidence about the substance alone does not establish a product’s identity, registration or quality.
Related information
For general questions about names or label details, contact LINE: @musclestationth
Sources and review date
Sources checked: 11 September 2026. This page explains selected primary sources; it is not a systematic review of every study.